Nature Reviews Clinical Oncology, Published online: 14 April 2026; doi:10.1038/s41571-026-01141-2 Myelodysplastic neoplasms (MDS) comprise a heterogeneous group of malignancies that can lead to ineffective haematopoiesis, cytopenias and, potentially, progression to acute myeloid leukaemia. In this Review, the authors describe the epidemiology of MDS, which appears to be rising, as well as advances in diagnosis, risk stratification and clinical management.
Nature Reviews Clinical Oncology published a clinical update in Oncology on 14 Apr 2026.
The item focuses on A 2026 update on myelodysplastic neoplasms: current state, challenges and future directions.
Review the original article for the full source wording and details.